Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis (Q36182744)

12 August 2017

1 reference

title

Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis (English)

1 reference

12 August 2017

J H Butterfield

1

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

114

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

26-40

1 reference

12 August 2017

1 reference

The eosinophilias, including the idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

21 January 2018

1 reference

Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia.

21 January 2018

1 reference

Clinical and cytogenetic remission induced by interferon-alpha in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation

21 January 2018

1 reference

Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases.

21 January 2018

1 reference

Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review

21 January 2018

1 reference

Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells.

21 January 2018

1 reference

Lymphocyte responses and cytokines

21 January 2018

1 reference

Mechanisms of eosinophil recruitment

21 January 2018

1 reference

Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells

21 January 2018

1 reference

Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome

21 January 2018

1 reference

Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report

21 January 2018

1 reference

Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality.

21 January 2018

1 reference

Eosinophilia and multiple erythematous indurated plaques. Idiopathic hypereosinophilic syndrome (IHS).

21 January 2018

1 reference

Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa.

21 January 2018

1 reference

Historical review: Cytokines as therapeutics and targets of therapeutics

21 January 2018

1 reference

Interferons and their actions

21 January 2018

1 reference

Hypereosinophilic syndrome or chronic eosinophilic leukemia: report of a case with a lytic bone lesion

21 January 2018

1 reference

Diagnosis and treatment of systemic mastocytosis: state of the art.

21 January 2018

1 reference

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

21 January 2018

1 reference

Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior

21 January 2018

1 reference

Response of severe systemic mastocytosis to interferon alpha

21 January 2018

1 reference

Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case

21 January 2018

1 reference

Tripe palms associated with systemic mastocytosis: the role of transforming growth factor-alpha and efficacy of interferon-alfa

21 January 2018

1 reference

Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients

21 January 2018

1 reference

Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.

21 January 2018

1 reference

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.

21 January 2018

1 reference

Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage.

21 January 2018

1 reference

Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy

21 January 2018

1 reference

Aggressive systemic mastocytosis

21 January 2018

1 reference

Treatment of the Hypereosinophilic Syndrome with Interferon-α

21 January 2018

1 reference

Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000085560

1 reference

12 August 2017

1 reference